Fuisz Pharma Acquires Key Patent To Complement Anti Opiate Abuse Platform
Joseph Matus Fuisz, president of Fuisz Pharma, said: “The technology described in the acquired patent is highly complementary to the anti abuse portfolio that we previously announced. Importantly,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.